NL188408C - 1-(4-amino-3,5-dichloorfenyl)-2-(gesubstitueerd amino)-ethanolverbinding met beta2-adrenoreceptoren stimulerende werking; farmaceutisch preparaat. - Google Patents
1-(4-amino-3,5-dichloorfenyl)-2-(gesubstitueerd amino)-ethanolverbinding met beta2-adrenoreceptoren stimulerende werking; farmaceutisch preparaat.Info
- Publication number
- NL188408C NL188408C NLAANVRAGE8700326,A NL8700326A NL188408C NL 188408 C NL188408 C NL 188408C NL 8700326 A NL8700326 A NL 8700326A NL 188408 C NL188408 C NL 188408C
- Authority
- NL
- Netherlands
- Prior art keywords
- amino
- adrenoreceptors
- beta2
- dichlorophenyl
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868603475A GB8603475D0 (en) | 1986-02-12 | 1986-02-12 | Chemical compounds |
| GB8603475 | 1986-02-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8700326A NL8700326A (nl) | 1987-09-01 |
| NL188408B NL188408B (nl) | 1992-01-16 |
| NL188408C true NL188408C (nl) | 1992-06-16 |
Family
ID=10592944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE8700326,A NL188408C (nl) | 1986-02-12 | 1987-02-11 | 1-(4-amino-3,5-dichloorfenyl)-2-(gesubstitueerd amino)-ethanolverbinding met beta2-adrenoreceptoren stimulerende werking; farmaceutisch preparaat. |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US4937251A (nl) |
| JP (2) | JPS62258359A (nl) |
| KR (1) | KR870007886A (nl) |
| CN (1) | CN1020095C (nl) |
| AT (1) | AT394364B (nl) |
| AU (1) | AU596824B2 (nl) |
| BE (1) | BE1002129A3 (nl) |
| CA (1) | CA1301762C (nl) |
| CH (1) | CH670636A5 (nl) |
| CS (1) | CS402991A3 (nl) |
| CY (1) | CY1660A (nl) |
| DE (1) | DE3704223C2 (nl) |
| DK (1) | DK163991C (nl) |
| ES (1) | ES2004676A6 (nl) |
| FI (1) | FI83774C (nl) |
| FR (1) | FR2596049B1 (nl) |
| GB (2) | GB8603475D0 (nl) |
| GR (1) | GR870220B (nl) |
| HK (1) | HK85790A (nl) |
| HU (1) | HU199416B (nl) |
| IE (1) | IE59524B1 (nl) |
| IL (2) | IL81535A (nl) |
| IS (1) | IS1489B (nl) |
| IT (1) | IT1205978B (nl) |
| LU (1) | LU86768A1 (nl) |
| MX (1) | MX5220A (nl) |
| NL (1) | NL188408C (nl) |
| NO (1) | NO170629C (nl) |
| NZ (1) | NZ219241A (nl) |
| PH (1) | PH24067A (nl) |
| PL (1) | PL151050B1 (nl) |
| PT (1) | PT84273B (nl) |
| SE (1) | SE462562B (nl) |
| SG (1) | SG70590G (nl) |
| SU (1) | SU1590042A3 (nl) |
| ZA (1) | ZA87974B (nl) |
| ZW (1) | ZW2887A1 (nl) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8703007D0 (en) * | 1987-02-10 | 1987-03-18 | Glaxo Group Ltd | Chemical compounds |
| US5149698A (en) * | 1987-08-11 | 1992-09-22 | Glaxo Group Limited | Chloroaniline derivatives |
| GB8718939D0 (en) * | 1987-08-11 | 1987-09-16 | Glaxo Group Ltd | Chemical compounds |
| ES2039646T3 (es) * | 1987-11-13 | 1993-10-01 | Glaxo Group Limited | Derivados de fenetanolamina. |
| KR920000717A (ko) * | 1990-03-05 | 1992-01-29 | 원본미기재 | 디클로로아닐린 화합물 |
| GB9104650D0 (en) * | 1991-03-05 | 1991-04-17 | Glaxo Group Ltd | Medicaments |
| US6419873B1 (en) | 1999-03-19 | 2002-07-16 | Q2100, Inc. | Plastic lens systems, compositions, and methods |
| US6436972B1 (en) | 2000-04-10 | 2002-08-20 | Dalhousie University | Pyridones and their use as modulators of serine hydrolase enzymes |
| TWI249515B (en) | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| JP4575153B2 (ja) * | 2002-06-18 | 2010-11-04 | 旭化成エレクトロニクス株式会社 | 電流測定方法および電流測定装置 |
| US20070219223A1 (en) * | 2006-03-07 | 2007-09-20 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
| JP5626621B2 (ja) | 2010-03-19 | 2014-11-19 | 株式会社 日立産業制御ソリューションズ | フェイズドアレイ合成開口ソナーシステム |
| US9012450B2 (en) | 2011-12-28 | 2015-04-21 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| HUE035069T2 (en) | 2011-12-28 | 2018-05-02 | Global Blood Therapeutics Inc | Substituted benzaldehyde compounds and their use to increase tissue oxygenation |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| PE20160078A1 (es) | 2013-03-15 | 2016-03-02 | Global Blood Therapeutics Inc | Compuestos y sus usos para modular la hemoglobina |
| US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| CA2903022C (en) | 2013-03-15 | 2021-11-09 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| CN105073728A (zh) | 2013-03-15 | 2015-11-18 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| AP2016009261A0 (en) | 2014-02-07 | 2016-06-30 | Global Blood Therapeutics Inc | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
| MX2018006832A (es) | 2015-12-04 | 2018-11-09 | Global Blood Therapeutics Inc | Regimenes de dosificacion de 2-hidroxi-6-((2-(1-isopropil-1h-piraz ol-5-il)-piridin-3-il)-metoxi)-benzaldehido. |
| TWI752307B (zh) | 2016-05-12 | 2022-01-11 | 美商全球血液治療公司 | 新穎化合物及製造化合物之方法 |
| TW202332423A (zh) | 2016-10-12 | 2023-08-16 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
| WO2020072377A1 (en) | 2018-10-01 | 2020-04-09 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin for the treatment of sickle cell disease |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1618005A1 (de) * | 1966-09-22 | 1971-09-09 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen |
| NL176168C (nl) * | 1972-12-18 | 1985-03-01 | Thomae Gmbh Dr K | Werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare nieuwe gesubstitueerde 1-(4-aminofenyl)-2-amino-ethanol-derivaten die, behalve een analgetische, uterusspasmolytische en anti-spastische werking op de dwarsgestreepte spieren, in het bijzonder een beta2-mimetische en/of beta1-blokkerende werking bezitten. |
| DE2711655A1 (de) * | 1977-03-17 | 1978-09-21 | Basf Ag | Pyridinyl-aminoalkylaether |
| CH635320A5 (en) * | 1978-01-01 | 1983-03-31 | Ciba Geigy Ag | 1-(Azacyclic aralkoxyphenyl)-2- or -3-(bis-arylalkylamino)alkanes |
| ATE1899T1 (de) * | 1979-06-16 | 1982-12-15 | Beecham Group Plc | Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen. |
| NL8105170A (nl) * | 1980-12-10 | 1982-07-01 | Thomae Gmbh Dr K | Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen. |
| US4379166A (en) * | 1981-08-03 | 1983-04-05 | Schering Corporation | Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols |
| HU186654B (en) * | 1982-12-28 | 1985-09-30 | Richter Gedeon Vegyeszet | Process for producing new pyridine derivatives, acid additional salts and quaternary salts and pharmaceutical compositions containing them |
| DE3434271A1 (de) * | 1984-09-19 | 1986-03-20 | Beiersdorf Ag, 2000 Hamburg | Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
| GB8426191D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
| GB8525484D0 (en) * | 1985-10-16 | 1985-11-20 | Glaxo Group Ltd | Chemical compounds |
| GB8718939D0 (en) * | 1987-08-11 | 1987-09-16 | Glaxo Group Ltd | Chemical compounds |
-
1986
- 1986-02-12 GB GB868603475A patent/GB8603475D0/en active Pending
-
1987
- 1987-02-10 IS IS3193A patent/IS1489B/is unknown
- 1987-02-10 GR GR870220A patent/GR870220B/el unknown
- 1987-02-11 BE BE8700109A patent/BE1002129A3/fr not_active IP Right Cessation
- 1987-02-11 CH CH527/87A patent/CH670636A5/fr not_active IP Right Cessation
- 1987-02-11 LU LU86768A patent/LU86768A1/fr unknown
- 1987-02-11 FI FI870554A patent/FI83774C/fi not_active IP Right Cessation
- 1987-02-11 NL NLAANVRAGE8700326,A patent/NL188408C/nl not_active IP Right Cessation
- 1987-02-11 SE SE8700535A patent/SE462562B/sv not_active IP Right Cessation
- 1987-02-11 US US07/013,895 patent/US4937251A/en not_active Expired - Fee Related
- 1987-02-11 PH PH34850A patent/PH24067A/en unknown
- 1987-02-11 ES ES8700341A patent/ES2004676A6/es not_active Expired
- 1987-02-11 ZA ZA87974A patent/ZA87974B/xx unknown
- 1987-02-11 NO NO870526A patent/NO170629C/no unknown
- 1987-02-11 NZ NZ219241A patent/NZ219241A/en unknown
- 1987-02-11 AT AT0028687A patent/AT394364B/de not_active IP Right Cessation
- 1987-02-11 AU AU68695/87A patent/AU596824B2/en not_active Ceased
- 1987-02-11 DE DE3704223A patent/DE3704223C2/de not_active Expired - Fee Related
- 1987-02-11 PL PL1987264054A patent/PL151050B1/pl unknown
- 1987-02-11 IT IT47630/87A patent/IT1205978B/it active
- 1987-02-11 IL IL81535A patent/IL81535A/xx not_active IP Right Cessation
- 1987-02-11 CN CN87101830A patent/CN1020095C/zh not_active Expired - Fee Related
- 1987-02-11 DK DK069887A patent/DK163991C/da active
- 1987-02-11 IE IE35087A patent/IE59524B1/en not_active IP Right Cessation
- 1987-02-11 GB GB8703059A patent/GB2187734B/en not_active Expired - Fee Related
- 1987-02-11 PT PT84273A patent/PT84273B/pt not_active IP Right Cessation
- 1987-02-11 FR FR878701698A patent/FR2596049B1/fr not_active Expired - Fee Related
- 1987-02-11 SU SU874202054A patent/SU1590042A3/ru active
- 1987-02-11 HU HU87530A patent/HU199416B/hu not_active IP Right Cessation
- 1987-02-11 ZW ZW28/87A patent/ZW2887A1/xx unknown
- 1987-02-12 MX MX522087A patent/MX5220A/es unknown
- 1987-02-12 KR KR870001162A patent/KR870007886A/ko not_active Application Discontinuation
- 1987-02-12 CA CA000529552A patent/CA1301762C/en not_active Expired - Fee Related
- 1987-02-12 JP JP62030644A patent/JPS62258359A/ja active Granted
-
1989
- 1989-02-07 IL IL89205A patent/IL89205A/xx not_active IP Right Cessation
-
1990
- 1990-05-21 JP JP2131124A patent/JPH0314565A/ja active Pending
- 1990-08-24 SG SG705/90A patent/SG70590G/en unknown
- 1990-10-18 HK HK857/90A patent/HK85790A/xx not_active IP Right Cessation
-
1991
- 1991-12-23 CS CS914029A patent/CS402991A3/cs unknown
-
1993
- 1993-05-14 CY CY1660A patent/CY1660A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL188408C (nl) | 1-(4-amino-3,5-dichloorfenyl)-2-(gesubstitueerd amino)-ethanolverbinding met beta2-adrenoreceptoren stimulerende werking; farmaceutisch preparaat. | |
| NL195004B (nl) | Fenylcarbamaat bevattend farmaceutisch preparaat. | |
| FI860559A0 (fi) | 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
| NL194239B (nl) | Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten. | |
| NO870961L (no) | Fast, tannsten-motvirkende munnpleiemiddel. | |
| FI873010A0 (fi) | Nitrofuranderivat, deras framstaellning och deras terapeutiska tillaempning. | |
| DE3777273D1 (de) | Omega-substituierte, optisch aktive 2-alkanolesterabkoemmlinge. | |
| NL970029I1 (nl) | Benzimidazoolderivaten, bereiding en therapeutische toepassing. | |
| FI874020A (fi) | Tetrahydrokinolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande farmaceutiska preparat. | |
| NO890187D0 (no) | 2-(3,4-dihydroksyfenyl)etylaminer, deres fremstilling og anvendelse som farmasoeytika. | |
| FI873798A0 (fi) | Aminoglykosidsteroider, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma. | |
| FI874382A (fi) | Farmaceutiska preparat. | |
| FI884545A (fi) | Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar. | |
| FI873799A (fi) | Aminoglykosidsteroider, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma. | |
| DE3779562D1 (de) | Golgi-alpha-mannosidase ii-inhibitoren enthaltende zubereitungen. | |
| NL194043B (nl) | 5-Fluoruracilderivaat, alsmede een dergelijk derivaat omvattend farmaceutisch preparaat met kankerbestrijdende werking. | |
| FI870732A0 (fi) | Glycero-3(2)-fosfo-l-serinderivat och deras salter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
| NO873628D0 (no) | 2,3-dihydro-1h-fenalen-2-amino-forbindelser som antipsykotiske legemidler. | |
| IT8621695A0 (it) | Preparazione farmaceutica per uso veterinario. | |
| DK222888D0 (da) | Anellerede heteroalkylenquinolinaminer, isomere og salte deraf, deres fremstilling og anvendelse som laegemidler smat mellemprodukter til fremstillingen | |
| TR25921A (tr) | PESTISID ETKINLIGI HAIZ PESTISID ÖZELLIKTE BISIKLOOKTANLAR,BUNLARI IHTIVA EDEN FORMüLASYONLAR VE HAZIRLANMALARINA MAHSUS USULLER. | |
| IT9022507A0 (it) | Procedimento per la preparazione di n-(26ammino63,5-dibromo-benzil)-trans-4-amminocicloesanolo3. | |
| IT8519730A0 (it) | Composto attivante il circolo cerebrale e periferico, metodo per la sua preparazione e composizioni farmaceutiche. | |
| IT8419520A0 (it) | Composto attivante il circolo cerebrale e periferico, metodo per la sua preparazione e composizioni farmaceutiche. | |
| NO881014D0 (no) | Xylometazolinholdige, farmasoeytiske midler. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| V1 | Lapsed because of non-payment of the annual fee |
Effective date: 20010901 |